Autophagy in the physiological endometrium and cancer

被引:134
作者
Devis-Jauregui, Laura [1 ]
Eritja, Nuria [2 ]
Davis, Meredith Leigh [3 ]
Matias-Guiu, Xavier [1 ,2 ,4 ]
Llobet-Navas, David [1 ]
机构
[1] Bellvitge Biomed Res Inst IDIBELL, Lab Precis Med, Oncobell Program, Gran Via Hospitalet,199, Barcelona 08908, Spain
[2] Univ Lleida, Hosp Univ Arnau Vilanova, Dept Pathol, IRBLLEIDA,CIBERONC, Lleida, Spain
[3] Newcastle Univ, Int Ctr Life, Inst Genet Med, Cent Pkwy, Newcastle Upon Tyne, Tyne & Wear, England
[4] Univ Bellvitge, Dept Pathol Hosp, Barcelona, Spain
关键词
Autophagy; endometrial cancer; endometrial hyperplasia; endometrium; menstrual cycle; obesity; reproduction; EXTERNAL-BEAM RADIOTHERAPY; ENDOTHELIAL GROWTH-FACTOR; CELL-CYCLE ARREST; MOLECULAR-MECHANISMS; MTOR INHIBITION; CARCINOMA-CELLS; METFORMIN; KINASE; CHEMOTHERAPY; EXPRESSION;
D O I
10.1080/15548627.2020.1752548
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Autophagy is a highly conserved catabolic process and a major cellular pathway for the degradation of long-lived proteins and cytoplasmic organelles. An increasing body of evidence has unveiled autophagy as an indispensable biological function that helps to maintain normal tissue homeostasis and metabolic fitness that can also lead to severe consequences for the normal cellular functioning when altered. Recent accumulating data point to autophagy as a key player in a wide variety of physiological and pathophysiological conditions in the human endometrium, one of the most proficient self-regenerating tissues in the human body and an instrumental player in placental species reproductive function. The current review highlights the most recent findings regarding the process of autophagy in the normal and cancerous endometrial tissue. Current research efforts aiming to therapeutically exploit autophagy and the methodological approaches used are discussed.
引用
收藏
页码:1077 / 1095
页数:19
相关论文
共 153 条
[1]   Targeting Autophagy in Cancer: Recent Advances and Future Directions [J].
Amaravadi, Ravi K. ;
Kimmelman, Alec C. ;
Debnath, Jayanta .
CANCER DISCOVERY, 2019, 9 (09) :1167-1181
[2]  
[Anonymous], 2007, J CLIN ONCOL
[3]   Autophagy in Normal and Abnormal Early Human Pregnancies [J].
Avagliano, Laura ;
Terraneo, Laura ;
Virgili, Eleonora ;
Martinelli, Carla ;
Doi, Patrizia ;
Samaja, Michele ;
Bulfamante, Gaetano Pietro ;
Marconi, Anna Maria .
REPRODUCTIVE SCIENCES, 2015, 22 (07) :838-844
[4]   EIN and WHO94 [J].
Baak, JPA ;
Mutter, GL .
JOURNAL OF CLINICAL PATHOLOGY, 2005, 58 (01) :1-6
[5]  
BAO XX, 2014, CHIN MED J, V464, P315
[6]   Bortezomib represses HIF-1α protein expression and nuclear accumulation by inhibiting both PI3K/Akt/TOR and MAPK pathways in prostate cancer cells [J].
Befani, Christina D. ;
Vlachostergios, Panagiotis J. ;
Hatzidaki, Eleana ;
Patrikidou, Anna ;
Bonanou, Sophia ;
Simos, George ;
Papandreou, Christos N. ;
Liakos, Panagiotis .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2012, 90 (01) :45-54
[7]   Molecular and cellular aspects of endometrial receptivity [J].
Beier, HM ;
Beier-Hellwig, K .
HUMAN REPRODUCTION UPDATE, 1998, 4 (05) :448-458
[8]   Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1 [J].
Ben Sahra, Isaam ;
Regazzetti, Claire ;
Robert, Guillaume ;
Laurent, Kathiane ;
Le Marchand-Brustel, Yannick ;
Auberger, Patrick ;
Tanti, Jean-Francois ;
Giorgetti-Peraldi, Sophie ;
Bost, Frederic .
CANCER RESEARCH, 2011, 71 (13) :4366-4372
[9]   Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results,, systematic review, and meta-analysis [J].
Blake, P. ;
Swart, Ann Marie ;
Orton, J. ;
Kitchener, H. ;
Whelan, T. ;
Lukka, H. ;
Eisenhauer, E. ;
Bacon, M. ;
Tu, D. ;
Parmar, M. K. B. ;
Amos, C. ;
Murray, C. ;
Qian, W. .
LANCET, 2009, 373 (9658) :137-146
[10]   2 PATHOGENETIC TYPES OF ENDOMETRIAL CARCINOMA [J].
BOKHMAN, JV .
GYNECOLOGIC ONCOLOGY, 1983, 15 (01) :10-17